Information about Etherna Immunotherapies
My details
*
*
*
{{translate('company_activity_bron_' + bron)}}
NACE Description
{{activiteit.code}} {{activiteit.description}}

Etherna Immunotherapies (SA)

BE 0502.703.389

Galileilaan 19, 2845 Niel
Company information
Status
Active
Enterprise number
BE0502.703.389
VAT liability
Yes
Established
21-01-2013
Last balance sheet year
2023
Company size
Big 68,6 FTE
Principal activity
Research and development in other physical and natural sciences
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Etherna Immunotherapies
{{translate("download")}}

Publications in the Belgian Official Journal from Etherna Immunotherapies

Date Publication
05-11-2024 Resignations - Appointments (NL)
25-06-2024 Articles of Association (Translation, Coordination, Other Modifications, …) - Miscellaneous (NL)
10-06-2024 Resignations - Appointments (NL)
16-06-2023 Resignations - Appointments (NL)
06-04-2023 Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of Etherna Immunotherapies?
The VAT number of Etherna Immunotherapies is BE0502703389.
When was Etherna Immunotherapies founded?
Etherna Immunotherapies was founded on 21-01-2013.
What is the address of Etherna Immunotherapies?
The current registered office of Etherna Immunotherapies is located at Galileilaan 19, 2845 Niel.
When was the last time Etherna Immunotherapies filed their annual financial statements?
The most recent financial statements of Etherna Immunotherapies were filed on 09-05-2024. You can view them here.
How many employees does Etherna Immunotherapies have?
There are 68,6 FTEs working at Etherna Immunotherapies according to the staff figures in the most recent financial statements.
What is the annual turnover of Etherna Immunotherapies?
At the time of its most recent financial statements, Etherna Immunotherapies recorded a total turnover of €6,796,302.50.

Sources